382 (Quetiapine Fumarate Extended-Release 200 mg)
Pill with imprint 382 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 200 mg. It is supplied by ScieGen Pharmaceuticals, Inc..
Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 382
Quetiapine Fumarate Extended-Release
- Imprint
- 382
- Strength
- 200 mg
- Color
- Yellow
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ScieGen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50228-0382
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
trisodium citrate dihydrate,
magnesium stearate,
polyethylene glycol 400,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related Images for "382"
More about quetiapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1766 Reviews
- Drug class: atypical antipsychotics
- FDA Alerts (4)
Consumer resources
- Patient Information
- Quetiapine (Advanced Reading)
- Quetiapine Extended-Release Tablets
- Quetiapine Tablets
- Other brands
- Seroquel, Seroquel XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.